1Stein H,Mason DY,Gerdes J,et al.The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue:evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells[J].Blood,1985,66(4):848-858.
3ten Berge RL,Meijer CJ,Dukers DF,et a1.Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma[J]Blood,2002,99(12):4540-4546.
4Falini B,Pileri S,Zinzani PL,et a1.ALK+lymphoma:clinicopathological findings and outcome[J].Blood,1999,93(8):2697-2706.
二级参考文献29
1Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that R eed-Sternberg cells and histiocytic mtlignancies are derived from activated lymphoid cells. Blo
2Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 1994, 84:1361-1392.
3Jaffe ES, Harris NL, Diebold J, et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol, 1999, 111Suppl 1 :S8-S12.
4Kutok JL, Aster JC. Molecular biology of anaplastic lymphoma kinasepositive anaplastic large cell-lymphoma. J Clin Oncol, 2002, 20:3691-3702.
5Pileri S, Bocchia M, Baroni CD, et al. Anaplastic large cell lymphoma (CD30 +/Ki- + ): results of a prospective clinico-pathological study of 69 cases. Br J Haematol, 1994, 86:513-523.
6Wood CS, Hardman DL, Boni R, et al. Lack of the t (2; 5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30 + primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 1996, 88:1765-1770.
7Herbst H, Anagnostopoulos J, Heinze B, et al. ALK gene products in anaplastic large cell lymphomas and Hodgkin' s disease. Blood, 1995,86: 1694-1700.
8Herbst H, Sander C, Tronnier M, et al. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Br J Dermatol, 1997, 137:680-686.
9Headington JT, Roth MS, Schnitzer B. Regressing atypical histiocytosis:a review and critical appraisal. Sem Diag Pathol, 1987, 4:28-37.
10Zinzani PL, Martelli M, Magagnoli M, et al. Anaplastic large cell lymphoma Hodgkin's like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood, 1998, 92:790-794.
